Germany· DE-A57-eb6be96b26ff08cf
Maxalt Migräne
A medicinal product containing rizatriptan benzoate, registered in Germany by Organonhealthcare Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Rizatriptan Benzoate
- Manufacturer
- Organonhealthcare Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rizatriptan benzoate in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMAXALTOrganon LLC
- FinlandMaxaltN.V. Organon
- NorwayMaxaltN.V. Organon - Kloosterstraat
- SwedenMaxalt 10 mg TablettMedartuum AB
- BelgiumMaxalt 10 mgOrganon Belgium
- IrelandRizadia 5 mg oral lyophilisateOrganon Pharma (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Maxalt, Maxalt Rapitab
- Belgium · Maxalt, Maxalt Lyo
- Denmark · Maxalt Smelt, Rizatripan
- Spain · Maxalt, Maxalt Max
- Finland · Maxalt, Maxalt Rapitab
- France · Maxalt, Maxaltlyo
- United Kingdom (Northern Ireland) · Maxalt, Maxalt Melt
- Greece · Flixan, Maxalt
- Croatia · Maxalt Rpd
- Hungary · Calvinia
- Ireland · Rizadia
- Iceland · Maxalt Smelt, Rizatriptan Alvogen
- Italy · Emirizia, Maxalt
- Lithuania · Maxalt
- Luxembourg · Maxalt Lyo
- Latvia · Calvinia
- Malta · Rizatriptan Aurobindo Pharma (Malta)
- Netherlands · Maxalt, Maxalt Smelt
- Norway · Maxalt, Maxalt Rapitab
- Poland · Migrenofen
- Portugal · Maxalt, Rizatriptano Zim
- Romania · Maxalt
- Sweden · Maxalt, Maxalt Rapitab
- Slovakia · Maxalt Rpd
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/65589116-20db-48c7-91b6-7771f6711a8b GET /v1/drugs/65589116-20db-48c7-91b6-7771f6711a8b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Rizatriptan Benzoate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about rizatriptan benzoate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.